Patents by Inventor Jonas Rochus

Jonas Rochus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylalkanoyl pyridazines
    Patent number: 6479494
    Abstract: Arylalkanoylpyridazine derivatives of the formula I and the physiologically acceptable salts thereof in which R1, R2, R3, R4, Q and B have the meanings given in Claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumors, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases and AIDS.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: November 12, 2002
    Assignee: Merck Patent Gesellschaft Mit Beschraenkter Haftung
    Inventors: Jonas Rochus, Norbert Beier, Franz-Werner Kluxen, Michael Wolf
  • Thienopyrimidines
    Patent number: 6110920
    Abstract: Thienopyrimidines of the formula I ##STR1## and the physiologically acceptable salts thereof in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, X and n have the meanings given in Claim 1inhibit phosphodiesterase V and can be employed for the treatment of diseases of the cardiovascular system and for the therapy of impaired potency.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: August 29, 2000
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Jonas Rochus, Pierre Schelling, Franz-Werner Kluxen, Maria Christadler
  • Arylalkanoyl pyridazines
    Patent number: 6107295
    Abstract: Arylalkanoylpyridazine derivatives of the formula I ##STR1## and the physiologically acceptable salts thereof in whichR.sup.1, R.sup.2, R.sup.3, R.sup.4, Q and B have the meanings given in claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumors, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases and AIDS.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: August 22, 2000
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Jonas Rochus, Norbert Beier, Franz-Werner Kluxen, Michael Wolf